Ventas, Inc.

Equities

VTR

US92276F1003

Specialized REITs

Market Closed - Nyse 04:00:38 2024-03-18 pm EDT 5-day change 1st Jan Change
42.77 USD +0.68% Intraday chart for Ventas, Inc. -3.95% -14.19%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Evercore ISI Upgrades Ventas to Outperform From In Line, Price Target is $50 MT
Ventas, Inc. Declares First Quarter 2024 Dividend, Payable on April 18, 2024 CI
Ventas ramps up acquisitions in property for senior citizens : Ventas CEO MT
Transcript : Ventas, Inc. Presents at Citi's 2024 Global Property CEO Conference, Mar-05-2024 04:20 PM
Ventas Appoints Theodore Bigman and Joe V. Rodriguez to Board of Directors CI
Ventas, Inc. Announces Board Changes CI
Ventas Prices Senior Notes Offering MT
How long will this bullish phase last? Our Logo
Wells Fargo Downgrades Ventas to Equalweight From Overweight, Adjusts Price Target to $46 From $52 MT
ANALYST RECOMMENDATIONS : AbbVie, Doordash, Eli Lilly, Moderna, Hiscox... Our Logo
Transcript : Ventas, Inc., Q4 2023 Earnings Call, Feb 15, 2024
Healthcare REIT Ventas reports rise in Q4 FFO RE
Ventas Q4 Normalized FFO, Revenue Rise; 2024 FFO Guidance Set MT
Earnings Flash (VTR) VENTAS Reports Q4 Revenue $1.16B MT
Ventas, Inc. Provides Earnings Guidance for the Year 2024 CI
Ventas, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023 CI
'No Landing' scenarios swirl as markets recoil RE
Ventas, Inc. acquired Residence at Orchard Grove from Blue Moon Capital Partners LLC. CI
Sector Update: Health Care Stocks Weaker Late Afternoon MT
Sector Update: Health Care Stocks Softer Tuesday Afternoon MT
Ventas' Strong Growth to Flow Into 2024, 2025 Earnings, BofA Securities Says; Stock Upgraded to Buy MT
BofA Upgrades Ventas to Buy From Neutral on External Growth Opportunities, Adjusts Price Target to $53 From $48 MT
Ventas Confirms Receipt of Director Nominations from Land & Buildings CI
Ventas Says it Received Three Director Nominations from Activist Investor; Board to Issue Recommendation MT
Land & Buildings nominates 3 candidates in Ventas board challenge RE
Chart Ventas, Inc.
More charts
Ventas, Inc. specializes in owning and managing healthcare and medical-residential facilities. At the end of 2022, the group's portfolio included 1,237 assets consisting primarily of senior housing (802), medical office buildings (313), rehabilitation and long-term acute care facilities (36), laboratories and research facilities (32), skilled nursing facilities (16), medical and surgical facilities (13). Net sales are distributed geographically as follows: the United States (88.5%), Canada (10.9%) and the United Kingdom (0.6%).
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
20
Last Close Price
42.77 USD
Average target price
53.05 USD
Spread / Average Target
+24.04%
Consensus
  1. Stock
  2. Equities
  3. Stock Ventas, Inc. - Nyse
  4. News Ventas, Inc.
  5. Ventas : Mizuho Assumes Ventas at Neutral with $45 Price Target